L-Arabinose
Affiliate link: we may earn a commission at no extra cost to you. Disclosures
L-Arabinose. Sucrase inhibitor for glycemic control.
How it works. Inhibits intestinal sucrase.
What the research supports. 1 graded claims. Strongest: Reduces post-meal glucose (moderate).
How much to take. Typical dose: 1.5–3 g.
Side effects and interactions. 1 medication interaction listed. No serious side effects listed at normal doses.
Stacking. Pairs well with A high-quality multivitamin, Omega-3 (EPA/DHA).
Common forms. Available as Capsule or softgel, Powder, Sublingual or buccal, Liposomal liquid.
Key studies. 8 studies cited. The strongest are listed with links to PubMed.
Community. Experiences from people who have tried L-Arabinose. Anecdotes are not medical advice.
L-Arabinose. Sucrase inhibitor for glycemic control.
What it is
Sucrase inhibitor for glycemic control.
Food sources
How it works
Inhibits intestinal sucrase.
Pathways
- Inhibits intestinal sucrase
Effects
- ↓post-meal glucose decreases
What the research supports
Strong: consistent results across large trials or meta-analyses. Moderate: several trials, mostly positive. Limited: small or mixed studies. Preclinical: animal or cell research only.
As an Amazon Associate I earn from qualifying purchases. Look for USP, NSF or Informed Sport seals before you buy.
Side effects & interactions
Common side effects
- Bloating
Medication interactions
Always disclose L-Arabinose use to your prescriber — additive, antagonistic, or pharmacokinetic interactions are possible.
Check any supplement–medication combination with your pharmacist before starting.
Combines with
Pairs well
- A high-quality multivitaminCovers micronutrient cofactors that support most supplement pathways.
- Omega-3 (EPA/DHA)Foundational anti-inflammatory support that complements most regimens.
Common forms
- Capsule or softgel
- Powder
- Sublingual or buccal
- Liposomal liquid
Key studies
8 studies cited in total.
Opens current human and preclinical literature matching L-Arabinose and "Reduces post-meal glucose". Filter by RCT, meta-analysis, or year on the results page.
Opens current human and preclinical literature matching L-Arabinose and "randomized controlled trial". Filter by RCT, meta-analysis, or year on the results page.
Opens current human and preclinical literature matching L-Arabinose and "meta-analysis". Filter by RCT, meta-analysis, or year on the results page.
Discussion
Loading discussion…